We have used WT1-dendritic cell vaccine (WT1-DC), in which WT1 is recognized by dendritic cells ex vivo, for treatment and have reported successful responses in late-stage cancers that have failed chemotherapy [4-7]. Here, WT1 is linked to cancer.